Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Anal cancer
Closed
Phase 1/2
This trial is looking at adding pembrolizumab to chemoradiotherapy to improve treatment for anal cancer.
Recruitment start: 17 October 2020
Recruitment end: 30 May 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Richard Adams
Dr Mark Harrison
Cardiff University
Merck, Sharp & Dohme
Last reviewed: 4 June 2025
CRUK internal database number: 17942
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
